Exchange: NASDAQ·Updated 09:30 AM EDT

LIAN LianBio - ADR

$0.0595
$0.00
(0.00%)
Today
Mkt Cap$6.49M
Vol693.00

About LIAN

LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
50

Neutral Sentiment

How do you feel about LIAN?

Advertisement|Remove ads.